CAS: 143653-53-6 - Abciximab
Formula:Unspecified
- Sinonimi:
- Immunoglobulin G1, anti-(human integrin αIIbβ3) Fab fragment (human-mouse monoclonal c7E3 clone p7E3VHhCγ1 γ1-chain), disulfide with human-mouse monoclonal c7E3 clone p7E3VκhCκ κ-chain
- Immunoglobulin G1, (human-mouse monoclonal c7E3 clone p7E3VHhCγ1 Fab fragment anti-human glycoprotein IIb/IIIa receptor), disulfide with human-mouse monoclonal c7E3 clone p7E3VκhCκ light chain
- Abciximab
- CentoRx
- C 7E3
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | Abciximab REF: TM-T76844CAS: 143653-53-6 | SDS-PAGE:95.2%;SEC-HPLC:95.9% | 198,00 €~2.255,00 € | Mar 17 Dic 24 |
 | Abciximab REF: 3D-CLA1118CAS: 143653-53-6 | - - - | Prezzo su richiesta | Ven 27 Dic 24 |
Abciximab
CAS:143653-53-6
Abciximab: chimeric antibody, anti-platelet, blocks glycoprotein IIb/IIIa, vitronectin, Mac-1.
Purezza:
SDS-PAGE:95.2%;SEC-HPLC:95.9%
Colore e forma:
Liquid
Peso molecolare:
95.18 kDa
Ref: TM-T76844
| 1mg | 198,00 € | ||
| 5mg | 523,00 € | ||
| 10mg | 823,00 € | ||
| 25mg | 1.234,00 € | ||
| 50mg | 1.652,00 € | ||
| 100mg | 2.255,00 € |
Consegna stimata in Stati Uniti, il Martedì 17 Dicembre 2024
Ref: 3D-CLA1118
| Dimensione non definita | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Venerdì 27 Dicembre 2024
